Check-Cap (MBAI) Capital Expenditures Growth (3y) (2018 - 2023)
Check-Cap (MBAI) Capital Expenditures Growth (3y) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -6.49% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 93.09% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 7.36% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -3.55% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.12% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.41% |
| 10 | Check-Cap | 5.89 Mn | -793.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 39.72% |
| Jun 30, 2023 | 39.92% |
| Mar 31, 2023 | -4.48% |
| Dec 31, 2022 | -138.11% |
| Sep 30, 2022 | 4.24% |
| Jun 30, 2022 | -38.80% |
| Mar 31, 2022 | -305.48% |
| Dec 31, 2021 | -48.69% |
| Sep 30, 2021 | -343.95% |
| Jun 30, 2021 | -197.87% |
| Mar 31, 2021 | -220.75% |
| Dec 31, 2020 | -241.71% |
| Sep 30, 2020 | 22.29% |
| Jun 30, 2020 | -35.46% |
| Mar 31, 2020 | 4.77% |
| Dec 31, 2019 | -86.63% |
| Sep 30, 2019 | 1.95% |
| Jun 30, 2019 | -7.53% |
| Mar 31, 2019 | 58.51% |
| Dec 31, 2018 | -8.29% |